关注公众号
收藏产品 产品详情
分子别名（Synonym）
CLEC12A, MICL, CLL-1, CLL1, DCAL2, DCAL-2, CD371
表达区间及表达系统（Source）
PE-Labeled Human CLEC12A Protein, His Tag (CLA-HP245) is produced via conjugation of PE to Human CLEC12A Protein, His Tag with a new generation site-specific technology under Star Staining labeling platform. Human CLEC12A Protein, His Tag is expressed from human 293 cells (HEK293). It contains AA His 65 - Ala 265 (Accession # Q5QGZ9-2).
Predicted N-terminus: His
蛋白结构（Molecular Characterization）
This protein carries a polyhistidine tag at the N-terminus.
偶联（Conjugate）
PE
Excitation Wavelength: 488 nm / 561 nm
Emission Wavelength: 575 nm
纯度（Purity）
>90% as determined by SDS-PAGE.
制剂（Formulation）
Lyophilized from 0.22 μm filtered solution in PBS, 0.2% BSA, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法（Reconstitution）
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储（Storage）
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
质量管理控制体系（QMS）
推荐产品
数据展示
CAR阳性表达率检测（Evaluation of CAR expression）
FACS Analysis of Anti-CLEC12A CAR Expression
5e5 of anti-CLEC12A/CLL-1 CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human CLEC12A Protein, His Tag (Cat. No. CLA-HP245) and negative control protein respectively (Fig. C and B), and non-transfected 293 cells were used as a control (Fig. A). PE signal was used to evaluate the binding activity (QC tested).
ProtocolFACS Analysis of Non-specific binding to PBMCs
5e5 of PBMCs were stained with PE-Labeled Human CLEC12A Protein, His Tag (Cat. No. CLA-HP245) and anti-CD3 antibody, washed and then analyzed with FACS. FITC signal was used to evaluate the expression of CD3+ T cells in PBMCs, and PE signal was used to evaluate the non-specific binding activity to PBMCs (QC tested).
Protocol
用户评价 发表评论
药物研发进展 
联系我们 
项目合作 